News
The surgery robotics developer will use the funds to reach fast-growing cities in China and develop solutions to treat major diseases.
OMERS Growth Equity and Kaiser Permanente Group Trust led the round, with participation from McKesson Ventures and B Capital Group.
The digital cardiology platform is designed to give patients a comprehensive, equitable and accessible way to manage hypertension and heart disease.
Grand Rounds' CEO Owen Tripp will continue on as the CEO of the combined entity.
The health tech company teamed up with New York State's Department of Public Health to distribute the vaccines.
Also: Sano Genetics raises $3.2 million for genome sequencing and health research; Aavia launches Gen Z hormone health brand with $2.5 million seed funding.
DarioHealth buys into MSK with Upright Technologies acquisition and announces $70M private placement
The $31 million purchase will add new capabilities to DarioHealth's condition management and behavior change platform.
Kenzen’s wearable device is designed to keep frontline workers in hazardous environments safe by monitoring users' health metrics.
The financing will be used to expand its clinical research services internationally.
The company will use the funding to expand its teledermatology services and 600 specialists in the DACH region.